Pandemic treaty talks to the wire, likely to miss first deadline,
sources say
Send a link to a friend
[May 10, 2024]
By Jennifer Rigby
LONDON (Reuters) - Talks to draw up a global pact to help fight future
pandemics are likely to miss an initial deadline on Friday, three
sources close to the process said.
Negotiators from the World Health Organization’s 194 member states were
hoping to have a final draft agreement by the end of Friday, with a view
toward adopting the legally-binding text at the World Health Assembly
later this month.
Instead talks on the text may have to continue, sources said, as
countries grapple with key sticking points.
"There is no chance at all of us reaching agreement by Friday," said one
Western diplomat.
The aim of the document, alongside a series of updates to existing rules
on dealing with pandemics, is to shore up the world’s defences against
new pathogens after the COVID-19 pandemic killed millions of people.
But there have been deep disagreements throughout the negotiating
process, particularly around equity. The accord, commonly known as a
treaty, has also become politicised in some countries.
"Talks will continue to Friday night, 00.00 hours,” Roland Driece, one
of the co-chairs of the intergovernmental negotiating body leading the
treaty talks, said in an email. "Then, we will discuss where we stand
and what needs to be done."
WHO chief Tedros Adhanom Ghebreyesus said this week teams were “strongly
committed to finalizing the agreement in time for the World Health
Assembly.”
VACCINE SHARING
Some of the treaty’s most contentious elements, including details around
a “pathogen access and benefits system”, have already been pushed back
for later discussion, with a deadline two years from now. The system
intends to codify sharing of material with pandemic potential, such as
new viruses or strains, and ensure that all countries benefit fairly
from vaccines, drugs and tests developed as a result.
The existing draft treaty includes a clause asking pharmaceutical
manufacturers to reserve 10% of such items to donate to the WHO, and 10%
for the agency to buy at affordable prices, to distribute in poorer
countries during health emergencies.
[to top of second column]
|
The World Health Organisation (WHO) logo is seen near its
headquarters in Geneva, Switzerland, February 2, 2023. REUTERS/Denis
Balibouse/File Photo
A report earlier this week in the
UK’s Telegraph newspaper said the UK would not sign a treaty the
country says would force it to give away a fifth of its vaccines.
Negotiations are ongoing, a WHO spokesperson said on Thursday.
An official involved in the talks said while most countries
supported a commitment to fairer vaccine access, a fixed percentage
was not finalized.
An existing agreement that governs pandemic influenza also has a
clause about selling vaccines at affordable prices or donating them
to WHO. It allows for between 5% and 20% for both options, to allow
for flexibility in negotiating with manufacturers.
This framework is what would be brought into play should the H5N1
strain of avian flu, which has raised alarm after being identified
in cows in the United States as well as among other animals and
birds, become easily transmissible between humans.
The WHO currently assesses that threat as low as there has been no
evidence of human-to-human spread.
External experts said losing political momentum for the pandemic
accord was a risk if there are delays, particularly in an election
year for many countries.
"It's not over til it's over," said Alexandra Phelan, a global
health law expert at Johns Hopkins University in Baltimore. "But
over is rapidly approaching."
(Reporting by Jennifer Rigby; Editing by Bill Berkrot)
[© 2024 Thomson Reuters. All rights reserved.]This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|